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Synthesis of analogues through redox reactions at position 16 of 
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 Abstract 
 　 Of the gedunin-type limonoids obtained from Chinese toon, or  Cedrela sinensis Juss. (Meliaceae), 
gedunin ( 1 ) 1 is a substance that can be isolated in relatively large quantities.  Acetylating gedunin 
( 1 ) readily results in 7 ― deacetoxy ― 7α ― hydroxygedunin ( 2 ).  A previous study 2 obtained gedunin 
analogues by reducing the 1 ― en ― 3 ― one structure of the A ring of gedunin ( 1 ), but no studies have 
obtained analogues by reducing the carbonyl group at position 16 on the D ring of gedunin ( 1 ) or 7 ―
 deacetoxy ― 7α ― hydroxygedunin ( 2 ).  In order to determine the chemical reactivity of lactone on the 
D ring of gedunin ( 1 ) and 7 ― deacetoxy ― 7α ― hydroxygedunin ( 2 ), the current authors facilitated redox 
reactions at position 16.  This allowed the synthesis of 2 known compounds, 7 ― oxogedunin ( 5 ) and 3
β ― hydroxygedunin ( 9 ), as well as 5 new analogues (compounds  3 ,  4 ,  6 ,  7 , and  8 ), as reported here.  
In order to determine the reactivity of gedunin ( 1 ), an attempt was made to reduce the substance 
with LiBH 4 and NaBH 4 .  LiBH 4 and NaBH 4 reduced the ketone at position 3 as well as the lactone-
carbonyl group at position 16, yielding a hemiacetal.  Further reduction failed to result in a 16 ―
 methylol form, indicating that this hemiacetal structure is highly stable.  When compound  8 was 
oxidized with MnO 2 , the hemiacetal hydroxyl group at position 16 was more readily oxidized than 
the allyl alcohol at position 3.  Limonoid analogues not found in nature were synthesized in order to 
determine the cytotoxic activity of different functional groups against tumor cells, and the cytotoxic 
activity of these compounds against P ― 388 murine leukemia cells was examined.  In compounds  3 ―
 8 , the carbonyl group at position 16 of the D ring of gedunin ( 1 ) was oxidized or reduced, and results 
indicated that these compounds lacked cytotoxic activity for the most part. 
 Keywords :  Gedunin-type limonoid, 7 ― Deacetoxy ― 7 α― hydroxygedunin, Redox reactions, P388 
murine leukemia cells 
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 1. Introduction 
 　 The mahogany family is known to contain large quantities of limonoids (a unique secondary 
metabolite with a 4,4,8 ― trimethyl ― 17 ― furanylsteroid skeleton) and triterpene compounds produced by 
precursors of limonoids.  Limonoids are found in the mahogany family ( Meliaceae ), in some members 
of the rue family ( Rutaceae ) and the Mediterranean relict shrub family ( Cneoraceae ), and the East 
African shrub  Harrisonia abbysinica ( Simaroubaceae ) .  Currently, over 300 limonoids have been 
isolated, and these compounds are anticipated to have useful bioactivities such as deterring insect 
feeding, antibacterial activity, and antiviral activity.  Gedunin-type compounds are limonoids from 
the mahogany family, and previous studies have reported that these compounds have antimalarial 
activity 3,4,5 as well as biological activity, e.g. inhibiting insect growth 2 or intake 6 . 
 　 A member of the mahogany family, the Chinese toon, or  Cedrela sinensis Juss., is a tall deciduous 
tree in the genus  Cedrela native to China.  The tree grows up to about 30 m tall, and its leaves are 
30 ― 50 cm long and pinnate, with an even or odd number of leaflets.  Leaflets are 10 ― 20 cm long and 
elliptical.  The leaves are used as vegetables and as medicine.  White flower clusters are produced 
in large panicles in June to July.  The timber is hard and shiny, and it is used as a building material, to 
make furniture, and for carving. 
 　 The current authors previously isolated and determined the structure of 5 triterpenoids with 
an obacunone-type limonoid skeleton 7 , 7 triterpenoids with a gedunin-type limonoid skeleton 8 , 33 
triterpenoids with an apotirucallane skeleton 9,10 and 5 triterpenoids with a tirucallane skeleton 10 
from the seeds, leaves, branches, and bark of  C. sinensis .  In addition, gedunin ( 1 ) molecules have 
numerous functional groups, so a previous study 11 attempted to introduce fluorine atoms into 
gedunin-type limonoids via reaction with diethylaminosulfur trifluoride (DAST) in order to determine 
the chemical reactivity of those groups and to synthesize limonoid analogues not found in nature. 
Gedunin ( 1 ) is a gedunin-type limonoid that is isolated from  C. sinensis in relatively large quantities, 
and acetylation of that substance yields 7 ― deacetoxy ― 7α ― hydroxygedunin ( 2 ).  In the current study, 
those 2 substances were used in reactions (Scheme 1) in order to determine the chemical reactivity 
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of lactone on the D ring of the 2 substances. 
 2. Results and Discussion 
 2.1 Synthesis of analogue  3 
 　 7 ― deacetoxy ― 7α ― hydroxygedunin ( 2 ) was reduced with LiBH 4 in THF over a period of 1 h at room 
temperature.  This resulted in product  3 at a yield of 86% (Scheme 1).  This compound is a colorless, 
amorphous solid, and HRESIMS indicated that its molecular formula was C 26 H 38 O 6 .  Signals for 
carbons at positions 1 ― 3 of the A ring of this compound were noted at δ 26.3 (CH 2 , C ― 1), 38.5 (CH 2 , 
C ― 2), and 78.6 (CH, C ― 3) in the  13 C-NMR spectrum.  These signals exhibited large upfield shifts in 
comparison to the signals produced by compound  2 .  In addition, signals at  δH 1.51 (1H, m, H ― 1α), 
1.32 (1H, m, H ― 1β), 1.56 (1H, m, H ― 2α), 1.04 (1H, m, H ― 2β), and 3.29 (1H, m, H ― 3) were noted in 
the  1 H-NMR spectrum.  Signals at the 16 position of the D ring were noted at δ C 88.2 (CH) and δ H 
Scheme 1. Preparation of 3―9. Reagents and conditions: (i) LiBH4, THF, rt, 1 h, 86% for 
3, and 64% for 7; (ii) NaBH4, CeCl3・7H2O, MeOH, rt, 1 h, 45% for 4, 24% 
for 6, and 55% for 8; (iii) TPAP, NMO, 4 Å MS, CH2Cl2 /CH3CN, rt, 7 h, 58% 
for 5; (iv) MnO2, CH2Cl2 /CH3CN, rt, 2 h, 35% for 9.
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5.29 (1H, dd,  J ＝9.1, 1.3 Hz).  An NOE correlation was noted between H ― 3/H ― 5, between H ― 3/H 3 ― 28, 
between H ― 15/H ― 16, and between H ― 16/H 3 ― 18 in the NOESY spectrum.  Thus, this compound was 
determined to have a structure with 1,4 ― and 1,2 ― reduction of the 1 ― en ― 3 ― one structure of the A 
ring of compound  2 and both the hydroxyl group at position 3 and the hemiacetal hydroxyl group at 
position 16 in a β configuration. 
 2.2 Synthesis of analogue  4 
 　 Luche reduction of compound  2 was achieved NaBH 4 in methanol in the presence of cerous 
chloride heptahydrate (CeCl 3 ・7H 2 O).  This reaction took place over a period of 1 h at room 
temperature and resulted in product  4 at a yield of 45% (Scheme 1).  This compound is a colorless, 
amorphous solid, and HRESIMS indicated that its molecular formula was C 26 H 36 O 6 .  A signal for 
carbon at position 3 of the A ring of this compound was noted at δ 77.2 (CH) in the  13 C―NMR 
spectrum.  In addition, signals were noted at δ H 5.86 (1H, d,  J ＝10.5 Hz, H ― 1), 5.31 (1H, d,  J ＝10.5 
Hz, H ― 2), and 3.95 (1H, br s, H ― 3) in the  1 H―NMR spectrum.  Further 1,2 ― reduction of the A ring was 
evident.  Signals at position 16 of the D ring were noted at  C 88.1 (CH) and δ H 5.28 (br s), suggesting 
the existence of a hemiacetal structure.  An NOE correlation between H3 ― /H ― 5, between H ― 3/H 3 ― 28, 
between H ― 15/H ― 16, and between H ― 16/H 3 ― 18 was indicated in the NOESY spectrum, so both the 
hydroxyl group at position 3 and the hemiacetal hydroxyl group at position 16 were determined to be 
in a β configuration.  Thus, this compound was determined to have a structure in which the carbonyl 
groups at positions 3 and 16 of compound  2 were reduced. 
 2.3 Analogue  5 (7 ― oxogedunin) 
 　 Compound  2 was oxidized with tetrapropylammonium perruthenate (TPAP, Pr 4 N ＋  RuO 4 ― ) in 
methylene chloride in the presence of NMO (4 ― methylmorphorine  N ―oxide) and 4 Å molecular 
sieves, resulting in product  5 at a yield of 58%.  Based on HRESIMS findings and analysis of the 
2D NMR spectrum, the structure of compound  5 was verified to be that of the known compound 7 ―
 oxogedunin 12 . 
 2.4 Synthesis of analogue  6 
 　 Luche reduction of compound  5 was achieved with NaBH 4 in methanol in the presence of cerous 
chloride heptahydrate (CeCl 3 ・7H 2 O), resulting in product  6 at a yield of 24% (Scheme 1).  This 
compound is a colorless, amorphous solid, and HRESIMS indicated that its molecular formula was 
C 26 H 36 O 6 .  Signals for the carbons at positions 3 and 7 of this compound were noted at δ 77.2 (CH, 
C ― 3) and 77.8 (CH, C ― 7) in the  13 C―NMR spectrum, and proton signals were noted at δ H 3.89 (1H, br s, 
H ― 3) and 3.81 (1H, dd,  J ＝10.7, 4.7 Hz, H ― 7) in the  1 H―NMR spectrum.  Signals at the 16 position of 
the D ring were noted at  δC 88.5 (CH) and  δH 5.30 (m).  An NOE correlation was noted between H ―
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 3/H ― 5, between H ― 3/H 3 ― 28, between H ― 5/H ― 7, between H ― 7/H ― 9, between H ― 15/H ― 16, and between 
H ― 16/H 3 ― 18 in the NOESY spectrum, so the hydroxyl group at positions 3 and 7 and the hemiacetal 
hydroxyl group at position 16 were in a β configuration.  Thus, the structure of compound  6 was 
determined. 
 2.5 Synthesis of analogue  7 
 　 Gedunin ( 1 ) was reduced with LiBH 4 in THF, resulting in product  7 at a yield of 64% (Scheme 1). 
This compound is a colorless, amorphous solid, and HRESIMS indicated that its molecular formula 
was C 28 H 40 O 7 .  Signals for carbons at positions 1 ― 3 of the A ring of this compound were noted at δ 
26.5 (CH 2 , C ― 1), 38.5 (CH 2 , C ― 2), and 78.5 (CH, C ― 3) in the  13 C―NMR spectrum.  Signals were noted 
at  δH 1.54 (1H, m, H ― 1α), 1.33 (1H, m, H ― 1β), 1.69 (1H, m, H ― 2α), 1.04 (1H, m, H ― 2β), and 3.27 
(1H, m, H ― 3) in the  1 H―NMR spectrum.  Signals at the 16 position of the D ring were noted at  δC 
87.9 (CH) and δ H 5.13 (1H, dd,  J ＝8.8, 1.6 Hz).  An NOE correlation was noted between H3 ― /H ―
 5, between H ― 3/H 3 ― 28, between H ― 15/H ― 16, and between H ― 16/H 3 ― 18 in the NOESY spectrum, so 
both the hydroxyl group at position 3 and the hemiacetal hydroxyl group at position 16 were in a β 
configuration.  Thus, the structure of compound  7 was determined. 
 2.6 Synthesis of analogue  8 
 　 Luche reduction of compound  1 was achieved with NaBH 4 in methanol in the presence of cerous 
chloride heptahydrate (CeCl 3 ・7H 2 O), resulting in product  8 at a yield of 55% (Scheme 1).  This 
compound is a colorless, amorphous solid, and HRESIMS indicated that its molecular formula was 
C 28 H 38 O 7 .  A signal for carbon at position 3 of the A ring of this compound was noted at δ 77.2 (CH) 
in the  13 C-NMR spectrum.  In addition, signals at δ H 5.87 (1H, dd,  J ＝10.4, 1.8 Hz, H ― 1), 5.33 (1H, 
dd,  J ＝10.4, 1.8 Hz, H ― 2), and 3.91 (1H, br s, H ― 3) were noted in the  1 H-NMR spectrum.  Signals at 
the 16 position of the D ring were noted at  δC 87.8 (CH) and  δH 5.13 (1H, d,  J ＝6.0 Hz).  An NOE 
correlation was noted between H3 ― /H ― 5, between H ― 3/H 3 ― 28, between H ― 15/H ― 16, and between 
H ― 16/H 3 ― 18 in the NOESY spectrum, so both the hydroxyl group at position 3 and the hemiacetal 
hydroxyl group at position 16 were in a β configuration.  Thus, the structure of compound  8 was 
determined. 
 2.7 Synthesis of analogue  9 (3β ― hydroxygedunin) 
 　 Selective oxidation of allyl alcohol in compound  8 was attempted with manganese dioxide (MnO 2 ) 
in dichloromethane.  This produced compound  9 , which had oxidization only at position 16 of the D 
ring and not at position 3 of the A ring.  Based on HRESIMS findings and the 2D NMR spectrum, 
compound  9 was verified to be the known compound 3β ― hydroxygedunin 13 . 
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 　 As stated above, the lactone-carbonyl group at position 16 of the D ring of a gedunin-type limonoid 
was readily reduced to a hydroxyl group by LiBH 4 or NaBH 4 in the presence of cerous chloride.  In 
addition, oxidation of compound  8 with MnO 2 resulted in more ready oxidation of the hemiacetal 
hydroxyl group at position 16 than of the allyl alcohol at position 3 of the A ring.  Although the 
reduced form had a hemiacetal structure, further reduction failed to result in a 16 ― methylol form, so 
this hemiacetal structure is extremely stable. 
 2.8.  Cytotoxicity assay of analogues of gedunin-type limonoids against P ― 388 murine 
leukemia cells 
 　 The 7 limonoid analogues synthesized in this study were subjected to a cytotoxicity assay using 
cells from mice with P ― 388 leukemia (Table 1). 
 　 Among the compounds in which the carbonyl group at position 16 of the D ring was oxidized or 
reduced, compounds  3 ― 8 lacked cytotoxic activity for the most part.  Compound  9 had an IC 50 of 8.3 
μg/mL, but this is extremely low in comparison to mitomycin C, which has an IC 50 of 0.029 μg/mL. 
Table 1. Cytotoxic activity of limonoid analogues against P―388 cells in vitro
Compound IC50 (μg/mL) Compound IC50 (μg/mL)
1
3
5
7
9
3.3
＞10
＞10
＞10
8.3
2
4
6
8
mitomycin C
4.5
＞10
＞10
＞10
0.029
 Experimental 
 3.1. General 
 　 During this experiment, various types of data were obtained using the following equipment. 
 　 Melting point: Yanaco MP ― 3, Optical rotation ([α] D ): JASCO P ― 1030, Mass spectra (MS): 
Micromass LCT, Infrared (IR) absorption spectra: JASCO FT/IR 620, Ultraviolet (UV) absorption 
spectra: JASCO V ― 530, and Nuclear magnetic resonance (NMR) spectra: Bruker AM- 500, DRX- 500, 
and AV ― 600.  NMR spectra were recorded by and data were processed using the software Bruker 
XWIN-NMR.  In addition, a chemical shift (δ) was expressed in units of ppm.  Prydine- d 5 { 1 H: 7.21 
ppm (C 5 D 4 HN),  
13 C: 135.5 ppm}, CDCl 3 { 
1 H: 7.26 ppm (CHCl 3 ),  
13 C: 77.03 ppm}, CD 3 OD { 
1 H: 3.31 
ppm (CD 2 HOD), and  
13 C: 49.0 ppm} were used as internal standards.  High-performance liquid 
chromatography (HPLC) was performed using the following system.  The pump used was the LC ―
 6AD (Shimadzu).  Compounds were detected with the SPD ― 10A UV/vis detector (Shimadzu).  The 
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column used was the Inertsil Prep-ODS (GL Sciences, Inc.) (6 mm i.d. ×250 mm, ODS, 10 μm, 20 
mm i.d. ×250 mm, ODS, 10 μm), the Wakosil-II 5C18HG (20 mm i.d. ×250 mm, ODS, 5 μm), or the 
Capcell Pak C18 UG 80 (10 mm i.d. ×250 mm, ODS, 5 μm).  Cytotoxic activity against p ― 388 murine 
leukemia cells was measured using methods previously reported 14 . 
 3.2. Reaction procedures 
 3.2.1 Conversion of compound  2 into compound  3 
 　 Lithium borohydride in THF (lithium borohydride/tetrahydrofuran, LiBH 4 /THF, ca. 2.0 mol/L, 
1 mL) was added to compound  2 (7 ― deacetoxy ― 7α ― hydroxygedunin, 16 mg, 0.036 mmol), and the 
resulting mixture was stirred for 1 h at room temperature.  The reaction solution was cooled to 0ºC, 
and then the reaction was halted by gradually adding 10% H 2 SO 4 (10 drops).  The solution was diluted 
with chloroform (30 mL), and the residue was rinsed with water (15 mL) and a saturated saline 
solution (15 mL).  The solution was dried with anhydrous magnesium sulfate and then filtered.  The 
solvent was removed under reduced pressure, and the resulting residue was purified using ODS 
HPLC (MeOH/H 2 O 60:40), resulting in compound  3 (14 mg, 86%). 
 　 Compound  3 : Colorless, amorphous solid; [α] 27D － 4.6 ( c 0.7, CHCl 3 );  1 H-NMR (500 MHz, CDCl 3 ) 
δ 7.33 (1H, m, H ― 21), 7.32 (1H, s, H ― 23), 6.29 (1H, d,  J ＝1.0 Hz, H ― 22), 5.29 (1H, dd,  J ＝9.1, 1.3 Hz, 
H ― 16), 5.02 (1H, s, H ― 17), 3.56 (1H, d,  J ＝1.6 Hz, H ― 15), 3.54 (1H, br s, H ― 7), 3.29 (1H, m, H ― 3), 2.17 
(1H, dd,  J ＝12.1, 6.1 Hz, H ― 9), 1.81 (1H, m, H ― 12β), 1.69 (1H, m, H ― 12α), 1.68 (1H, m, H ― 11α), 1.66 
(2H, m, H ― 6α and H ― 6β), 1.56 (1H, m, H ― 2α), 1.51 (2H, m, H ― 1α and H ― 1β), 1.48 (1H, m, H ― 5), 
1.32 (1H, m, H ― 1β), 1.22 (3H, s, H 3 ― 18), 1.04 (1H, m, H ― 2β), 0.96 (6H, s, H 3 ― 29 and H 3 ― 30), 0.91 (3H, 
s, H 3 ― 19), 0.78 (3H, s, H 3 ― 28);  13 C-NMR (125 MHz, CDCl 3 ) δ 142.2 (CH, C ― 23), 140.7 (CH, C ― 21), 
123.3 (C, C ― 20), 110.4 (CH, C ― 22), 88.2 (CH, C ― 16), 78.6 (CH, C ― 3), 72.7 (CH, C ― 17), 71.4 (CH, C ― 7), 
68.6 (C, C ― 14), 60.3 (CH, C ― 15), 46.9 (CH, C ― 5), 43.3 (CH, C ― 9), 43.0 (C, C ― 8), 38.5 (CH 2 , C ― 2), 38.4 
(C, C ― 10), 37.8 (C, C ― 13), 36.8 (C, C ― 4), 27.7 (CH 3 , C ― 28), 27.3 (CH 2 , C ― 6), 26.9 (CH 2 , C ― 12), 26.3 
(CH 2 , C ― 1), 18.9 (CH 3 , C ― 18), 18.4 (CH 3 , C ― 30), 16.5 (CH 3 , C ― 19), 15.5 (CH 3 , C ― 29), 15.3 (CH 2 , C ― 11); 
HRESIMS  m/z 469.2527 ([M＋Na] ＋ , calcd for C 26 H 38 O 6 Na, 469.2566). 
 3.2.2 Conversion of compound  2 into compound  4 
 　 Compound  2 (31 mg, 0.070 mmol) was dissolved in methanol (1 mL), a catalytic quantity of 
cerous chloride heptahydrate {cerium(III) chloride heptahydrate} and sodium borohydride (sodium 
borohydride, NaBH 4 , 13 mg, 0.34 mmol) were added, and the resulting mixture was stirred for 1 h 
at room temperature.  The reaction solution was cooled to 0ºC, and then the reaction was halted by 
gradually adding 10% H 2 SO 4 (10 drops).  The solution was diluted with chloroform (30 mL), and the 
residue was rinsed with water (15 mL) and a saturated saline solution (15 mL).  The solution was 
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dried with anhydrous magnesium sulfate and then filtered.  The solvent was removed under reduced 
pressure, and the resulting residue was purified using ODS HPLC (MeOH/H 2 O 60:40), resulting in 
compound  4 (14 mg, 45%). 
 　 Compound  4 : Colorless, amorphous solid; [α] 27D＋14 ( c 0.1, CHCl 3 );  1 H-NMR (500 MHz, CDCl 3 ) δ 
7.33 (1H, s, H ― 23), 7.31 (1H, s, H ― 21), 6.29 (1H, s, H ― 22), 5.86 (1H, d,  J ＝10.5 Hz, H ― 1), 5.31 (1H, d, 
 J ＝10.5 Hz, H ― 2), 5.28 (1H, br s, H ― 16), 5.01 (1H, s, H ― 17), 3.95 (1H, s, H ― 3), 3.57 (1H, s, H ― 15), 3.55 
(1H, br s, H ― 7), 2.33 (1H, dd,  J ＝12.7, 5.9 Hz, H ― 9), 1.97 (1H, m, H ― 5), 1.85 (1H, m, H ― 6α), 1.84 (1H, 
m, H ― 11α), 1.72 (1H, m, H ― 6β), 1.65 (1H, m, H ― 11β), 1.52 (1H, m, H ― 12β), 1.38 (1H, m, H ― 12α), 
1.19 (3H, s, H 3 ― 18), 1.07 (3H, s, H 3 ― 19), 0.98 (3H, s, H 3 ― 30), 0.97 (3H, s, H 3 ― 28), 0.83 (3H, s, H 3 ― 29); 
 13 C-NMR (125 MHz, CDCl 3 ) δ 142.2 (CH, C ― 23), 140.7 (CH, C ― 21), 137.6 (CH, C ― 1), 125.9 (CH, C ― 2), 
123.2 (C, C ― 20), 110.3 (CH, C ― 22), 88.1 (CH, C ― 16), 77.2 (CH, C ― 3), 72.7 (CH, C ― 17), 71.2 (CH, C ― 7), 
70.0 (C ― 14), 60.3 (CH, C ― 15), 44.7 (CH, C ― 5), 43.8 (C, C ― 8), 40.6 (CH, C ― 9), 39.7 (C, C ― 10), 36.7 (2C, 
C, C ― 4 and C ― 13), 27.4 (CH 3 , C ― 28), 26.7 (CH 2 , C ― 6), 26.4 (CH 2 , C ― 12), 19.7 (CH 3 , C ― 19), 19.1 (CH 3 , 
C ― 18), 18.7 (CH 3 , C ― 30), 17.5 (CH 3 , C ― 29), 15.7 (CH 2 , C ― 11); HRESIMS  m/z 427.2480 ([M－OH] ＋  , 
calcd for C 26 H 35 O 5 , 427.2484). 
 3.2.3 Conversion of compound  2 into compound  5 
 　 Compound  2 (33 mg, 0.075 mmol) was dissolved in dichloromethane/acetonitrile (10: 1, 2 
mL), 4 ― methylmorphorine  N -oxide (NMO, 13 mg, 0.11 mmol), 4Å molecular sieves (38 mg), and 
tetrapropylammonium perruthenate (TPAP, Pr 4 N 
＋ RuO 4 
- , 2.6 mg, 0.0074 mmol) were added, and the 
resulting mixture was stirred for 7 h at room temperature in an argon atmosphere.  The reaction 
solution was diluted with chloroform (30 mL), and the residue was rinsed with a saturated sodium 
sulfite solution (10 mL) and saturated saline solution (10 mL).  The solution was dried with anhydrous 
sodium sulfate and then filtered.  The solvent was removed under reduced pressure, and the resulting 
residue was purified using ODS HPLC (MeOH/H 2 O 60:40), resulting in compound  5 (19 mg, 58%). 
The  1 H-NMR spectrum and HRESIMS for this this compound agreed with previously reported 
findings for 7 ― oxogedunin 12 . 
 　 Compound  5 (7 ― oxogedunin): Colorless, amorphous solid; [α] 27 D  － 56( c 0.3, CHCl 3 ); HRESIMS  m/z 
439.2104 ([M＋H] ＋ , calcd for C 26 H 31 O 6 , 439.2121). 
 3.2.4 Conversion of compound  5 into compound  6 
 　 Compound  5 (7 ― oxogedunin, 19 mg, 0.043 mmol) was dissolved in methanol (1 mL), a catalytic 
amount of cerous chloride heptahydrate and sodium borohydride (7.8 mg, 0.21 mmol) were added, 
and the resulting mixture was stirred for 1 h at room temperature.  The reaction solution was cooled 
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to 0ºC, and then the reaction was halted by gradually adding 10% H 2 SO 4 (10 drops).  The solution 
was diluted with chloroform (30 mL), and the residue was rinsed with water (15 mL) and a saturated 
saline solution (15 mL).  The solution was dried with anhydrous magnesium sulfate and then filtered. 
The solvent was removed under reduced pressure, and the resulting residue was purified using ODS 
HPLC (MeOH/H 2 O 60:40), resulting in compound  6 (4.7 mg, 24%). 
 　 Compound  6 : Colorless, amorphous solid; [α] 27D ＋ 57 ( c 0.2, CHCl 3 );  1 H-NMR (500 MHz, CDCl 3 ) 
7.33 (2H, m, H ― 21 and H ― 23), 6.29 (1H, s, H ― 22), 5.83 (1H, dd,  J ＝10.3, 1.4 Hz, H ― 1), 5.34 (1H, dd, 
 J ＝10.3, 1.4 Hz, H ― 2), 5.30 (1H, m, H ― 16), 5.00 (1H, br s, H ― 17), 4.09 (1H, d,  J ＝1.5 Hz, H ― 15), 3.89 
(1H, br s, H ― 3), 3.81 (1H, dd,  J ＝10.7, 4.7 Hz, H ― 7), 1.88 (1H, m, H ― 9), 1.85 (1H, m, H ― 6α), 1.81 (1H, 
m, H ― 11β), 1.72 (1H, m, H ― 11α), 1.63 (1H, m, H ― 12β), 1.59 (1H, m, H ― 6β), 1.34 (1H, m, H ― 5), 1.31 
(1H, m, H ― 12α), 1.18 (3H, s, H 3 ― 18), 1.06 (3H, s, H 3 ― 19), 1.02 (3H, s, H 3 ― 30), 1.01 (3H, s, H 3 ― 28), 0.83 
(3H, s, H 3 ― 29);  13 C-NMR (125 MHz, CDCl 3 ) δ 142.3 (CH, C ― 23), 140.7 (CH, C ― 21), 137.0 (CH, C ― 1), 
126.6 (CH, C ― 2), 123.1 (C, C ― 20), 110.2 (CH, C ― 22), 88.5 (CH, C ― 16), 77.8 (CH, C ― 7), 77.2 (CH, C ― 3), 
72.7 (CH, C ― 17), 72.2 (C, C ― 14), 58.9 (CH, C ― 15), 51.3 (CH, C ― 5), 46.5 (CH, C ― 9), 45.2 (C, C ― 8), 39.3 
(C, C ― 10), 37.5 (C, C ― 13), 37.1 (C, C ― 4), 28.6 (CH 2 , C ― 6), 28.2 (CH 2 , C ― 12), 27.4 (CH 3 , C ― 28), 21.0 
(CH 3 , C ― 18), 19.4 (CH 3 , C ― 19), 17.3 (CH 3 , C ― 29), 16.8 (CH 2 , C ― 11), 13.1 (CH 3 , C ― 30); HRESIMS  m/z 
467.2402 ([M＋Na] ＋ , calcd for C 26 H 36 O 6 Na, 467.2410). 
 3.2.5 Conversion of compound  1 into compound  7 
 　 Lithium borohydride in THF (1 mL) was added to compound  1 (gedunin, 20 mg, 0.041 mmol), and 
the resulting mixture was stirred for 1 h at room temperature.  The reaction solution was cooled to 
0ºC, and then the reaction was halted by gradually adding 10% H 2 SO 4 (10 drops).  The solution was 
diluted with chloroform (30 mL), and the residue was rinsed with water (15 mL) and a saturated 
saline solution (15 mL).  The solution was dried with anhydrous magnesium sulfate and then filtered. 
The solvent was removed under reduced pressure, and the resulting residue was purified using ODS 
HPLC (MeOH/H 2 O 60:40), resulting in compound  7 (13 mg, 64%). 
 　 Compound  7 : Colorless, amorphous solid; [α]27 D  － 21 ( c 0.07, CHCl 3 );  1 H-NMR (500 MHz, CDCl 3 ) 
δ 7.34 (1H, s, H ― 23), 7.30 (1H, m, H ― 21), 6.29 (1H, s, H ― 22), 5.13 (1H, dd,  J ＝8.8, 1.6 Hz, H ― 16), 4.99 
(1H, s, H ― 17), 4.65 (1H, br s, H ― 7), 3.30 (1H, d,  J ＝1.6 Hz, H ― 15), 3.27 (1H, m, H ― 3), 2.21 (1H, m, H ― 9), 
2.12 (3H, s, OAc ― 7), 1.84 (1H, m, H ― 6α), 1.72 (1H, m, H ― 6β), 1.70 (1H, m, H ― 12β), 1.69 (1H, m, H ―
 2α), 1.68 (1H, m, H ― 11α), 1.62 (1H, m, H ― 12α), 1.54 (1H, m, H ― 1β), 1.53 (1H, m, H ― 11β), 1.33 (1H, 
s, H ― 1β), 1.32 (1H, m, H ― 5), 1.24 (3H, s, H 3 ― 18), 1.04 (1H, m, H ― 2β), 1.01 (3H, s, H 3 ― 30), 0.92 (3H, s, 
H 3 ― 19), 0.88 (3H, s, H 3 ― 28), 0.76 (3H, s, H 3 ― 29);  13 C-NMR (125 MHz, CDCl 3 ) δ 169.9 (C, O C OCH 3 ― 7), 
142.3 (CH, C ― 23), 140.7 (CH, C ― 21), 123.1 (CH, C ― 20), 110.3 (CH, C ― 22), 87.9 (CH, C ― 16), 78.5 (CH, 
― 44 ―
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C ― 3), 74.9 (CH, C ― 7), 72.5 (CH, C ― 17), 69.7 (C, C ― 14), 58.7 (CH, C ― 15), 48.2 (CH, C ― 5), 44.8 (CH, C ―
 9), 44.4 (C, C ― 8), 38.5 (CH 2 , C ― 2), 38.3 (C, C ― 10), 37.5 (C, C ― 13), 36.8 (C, C ― 4), 27.7 (CH 3 , C ― 28), 27.2 
(CH 2 , C ― 12), 26.5 (CH 2 , C ― 1), 23.4 (CH 2 , C ― 6), 21.4 (CH 3 , OCO C H 3 ― 7), 19.3 (CH 3 , C ― 18), 18.0 (CH 3 , 
C ― 30), 16.5 (CH 3 , C ― 19), 15.2 (CH 2 , C ― 11), 15.2 (CH 3 , C ― 29); HRESIMS  m/z 471.2734 ([M－OH] ＋  , 
calcd for C 28 H 39 O 6 , 471.2747). 
 3.2.6 Conversion of compound  1 into compound  8 
 　 Compound  1 (58 mg, 0.12 mmol) was dissolved in methanol (1 mL), a catalytic quantity of cerous 
chloride heptahydrate and sodium borohydride (23 mg, 0.61 mmol) were added, and the resulting 
mixture was stirred for 1 h at room temperature.  The reaction solution was cooled to 0ºC, and then 
the reaction was halted by gradually adding 10% H 2 SO 4 (10 drops).  The solution was diluted with 
chloroform (30 mL), and the residue was rinsed with water (15 mL) and a saturated saline solution (15 
mL).  The solution was dried with anhydrous magnesium sulfate and then filtered.  The solvent was 
removed under reduced pressure, and the resulting residue was purified using ODS HPLC (MeOH/
H 2 O 60:40), resulting in compound  8 (32 mg, 55%). 
 　 Compound  8 : Colorless, amorphous solid; [α] 27D － 23 ( c 0.2, CHCl 3 );  1 H-NMR (500 MHz, CDCl 3 ) δ
7.33 (2H, m, H ― 21 and H ― 23), 6.27 (1H, s, H ― 22), 5.87 (1H, dd,  J ＝10.4, 1.8 Hz, H ― 1), 5.33 (1H, dd, 
 J ＝10.4, 1.8 Hz, H ― 2), 5.13 (1H, d,  J ＝6.0 Hz, H ― 16), 4.98 (1H, br s, H ― 17), 4.65 (1H, d,  J ＝1.8 Hz, H ―
 7), 3.91 (1H, br s, H ― 3), 3.18 (1H, d,  J ＝1.6 Hz, H ― 15), 2.36 (1H, dd,  J ＝12.8, 5.3 Hz, H ― 9), 2.11 (3H, 
s, OAc ― 7), 1.89 (1H, m, H ― 6 α ), 1.85 (1H, m, H ― 11α), 1.78 (1H, m, H ― 5), 1.73 (1H, m, H ― 6β), 1.64 
(1H, m, H ― 11β), 1.52 (1H, m, H ― 12β), 1.37 (1H, m, H ― 12α), 1.22 (3H, s, H 3 ― 18), 1.08 (3H, s, H 3 ― 19), 
1.02 (3H, s, H 3 ― 30), 0.89 (3H, s, H 3 ― 28), 0.81 (3H, s, H 3 ― 29);  13 C-NMR (125 MHz, CDCl 3 ) δ 169.9 (C, 
O C OCH 3 ― 7), 142.3 (CH, C ― 23), 140.7 (CH, C ― 21), 137.3 (CH, C ― 1), 126.1 (CH, C ― 2), 123.0 (C, C ― 20), 
110.2 (CH, C ― 22), 87.8 (CH, C ― 16), 77.2 (CH, C ― 3), 74.5 (CH, C ― 7), 72.5 (CH, C ― 17), 69.4 (C, C ― 14), 
58.6 (CH, C ― 15), 46.1 (CH, C ― 5), 43.0 (C, C ― 8), 42.0 (CH, C ― 9), 39.5 (C, C ― 10), 36.8 (C, C ― 13), 36.6 
(C, C ― 4), 27.5 (CH 3 , C ― 28), 26.7 (CH 2 , C ― 12), 23.2 (CH 2 , C ― 6), 21.4 (CH 3 , OCO C H 3 ― 7), 19.7 (CH 3 , C ―
 19), 19.5 (CH 3 , C ― 18), 18.2 (CH 3 , C ― 30), 17.1 (CH 3 , C ― 29), 15.6 (CH 2 , C ― 11); HRESIMS  m/z 469.2573 
([M－OH] ＋ , calcd for C 28 H 37 O 6 , 469.2590). 
 3.2.7 Conversion of compound  8 into compound  9 
 　 Compound  8 (37 mg, 0.077 mmol) was dissolved in dichloromethane (2 mL), manganese dioxide 
(MnO 2 , 198 mg, 2.3 mmol) was added, and the resulting mixture was stirred for 2 h at room 
temperature.  The reaction solution was diluted with chloroform (30 mL) and filtered.  The solvent 
was then removed under reduced pressure, and the resulting residue was purified using ODS HPLC 
(MeOH/H 2 O 65: 35), resulting in compound  9 (13 mg, 35%).  The  
1 H-NMR spectrum and HRESIMS 
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results for this this compound agreed with previously reported findings for 3β ― hydroxygedunin 13 . 
 　 Compound  9 ( 3β ― hydroxygedunin ) : Colorless, amorphous solid; [α] 27 D ＋ 31 ( c 0.6, CHCl 3 ); 
HRESIMS  m/z 485.2536 ([M＋H] ＋ , calcd for C 28 H 37 O 7 , 485.2539). 
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